Foresite Capital Management V as of June 30, 2021
Portfolio Holdings for Foresite Capital Management V
Foresite Capital Management V holds 17 positions in its portfolio as reported in the June 2021 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Cullinan Oncology (CGEM) | 27.7 | $70M | 2.7M | 25.75 | |
| Quantum-Si Incorporated Com Cl A (QSI) | 11.3 | $29M | 2.3M | 12.26 | |
| Aclaris Therapeutics (ACRS) | 8.7 | $22M | 1.3M | 17.56 | |
| Kinnate Biopharma | 8.0 | $20M | 875k | 23.28 | |
| Gemini Therapeutics | 6.2 | $16M | 2.4M | 6.47 | |
| Relay Therapeutics (RLAY) | 5.8 | $15M | 400k | 36.59 | |
| Alx Oncology Hldgs (ALXO) | 5.0 | $13M | 231k | 54.68 | |
| Nurix Therapeutics (NRIX) | 4.7 | $12M | 452k | 26.53 | |
| Hims & Hers Health Com Cl A (HIMS) | 4.5 | $12M | 1.1M | 10.89 | |
| Population Health Investment Unit | 3.8 | $9.7M | 960k | 10.15 | |
| 23andMe Holding Com Cl A (ME) | 3.2 | $8.2M | 700k | 11.69 | |
| Pharvaris N V (PHVS) | 2.7 | $6.8M | 364k | 18.63 | |
| FS Development Corp. II Com Cl A | 2.4 | $6.0M | 603k | 9.98 | |
| Research Alliance Corp. II Com Cl A | 2.0 | $5.1M | 500k | 10.14 | |
| Bctg Acquisition Corp | 1.8 | $4.6M | 400k | 11.38 | |
| Lucira Health | 1.3 | $3.2M | 485k | 6.64 | |
| Helix Acquisition Corp. Com Cl A | 1.0 | $2.6M | 250k | 10.35 |
